Mr. Paul Baehr reports
IBEX TO LIVESTREAM ANNUAL MEETING ON FEBRUARY 16
The time of IBEX Technologies Inc.'s annual and special meeting of shareholders to be held on Wednesday, Feb. 16, 2022, has been changed to 11 a.m. ET.
IBEX also announces that, owing to the COVID-19 situation, shareholders are asked not to attend the meeting in person. In order to make the meeting accessible to shareholders and others, IBEX will livestream the meeting. To access the livestream meeting, please follow the instructions below:
- Log in on-line.
- Complete the short survey to register for the meeting.
- After registering, you will receive a confirmation e-mail sent to the e-mail address you provide in the survey.
- The day before the meeting, you will receive another confirmation e-mail with the link and instructions for the meeting.
Please log in by 10:45 a.m. ET on Feb. 16.
IBEX shareholders are encouraged to vote prior to the meeting by returning their proxy forms by 5 p.m. ET on Feb. 14, 2022. Only registered shareholders and duly appointed proxyholders will be entitled to vote at the meeting. Non-registered (or beneficial) shareholders who have not duly appointed themselves as proxyholders will be able to attend the livestream meeting as guests but will not be able to vote at the meeting.
About IBEX Technologies Inc.
IBEX manufactures and markets enzymes for biomedical use through its wholly owned subsidiary, IBEX Pharmaceuticals Inc. IBEX Pharmaceuticals also manufactures and markets a series of arthritis assays, which are widely used in osteoarthritis research.
© 2024 Canjex Publishing Ltd. All rights reserved.